Linkedin X-twitter
Search

+44 (0)20 7722 1221

[email protected]

VIEW OPPORTUNITIES

SHARE

ADEL strikes $1.04bn Alzheimer’s drug development partnership with Sanofi 

The South Korea-based biotech has agreed a deal with the French drugmaker covering development and commercialisation of its experimental therapy. The agreement includes an $80m upfront payment, milestones and future sales royalties.
Read the full article.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.